FCE 28073 structure
|
Common Name | FCE 28073 | ||
---|---|---|---|---|
CAS Number | 174756-44-6 | Molecular Weight | 302.34300 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C17H19FN2O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | N2-{4-[(3-Fluorobenzyl)oxy]benzyl}-D-alaninamide |
---|---|
Synonym | More Synonyms |
Molecular Formula | C17H19FN2O2 |
---|---|
Molecular Weight | 302.34300 |
Exact Mass | 302.14300 |
PSA | 65.34000 |
LogP | 3.90870 |
Storage condition | 2-8°C |
~88% FCE 28073 CAS#:174756-44-6 |
Literature: NEWRON PHARMACEUTICALS S.P.A. Patent: WO2009/74478 A1, 2009 ; Location in patent: Page/Page column 66 ; |
~% FCE 28073 CAS#:174756-44-6 |
Literature: NEWRON PHARMACEUTICALS S.P.A. Patent: WO2009/74478 A1, 2009 ; Location in patent: Page/Page column 71-72 ; |
~% FCE 28073 CAS#:174756-44-6 |
Literature: NEWRON PHARMACEUTICALS S.P.A. Patent: WO2009/74478 A1, 2009 ; Location in patent: Page/Page column 64-65 ; |
~% FCE 28073 CAS#:174756-44-6 |
Literature: Leonetti, Francesco; Capaldi, Carmelida; Pisani, Leonardo; Nicolotti, Orazio; Muncipinto, Giovanni; Stefanachi, Angela; Cellamare, Saverio; Caccia, Carla; Carotti, Angelo Journal of Medicinal Chemistry, 2007 , vol. 50, # 20 p. 4909 - 4916 |
2-hydroxy-N-propylnorapomorphine hydrobromide |